Our highly experienced team partners with our clients to deliver immunoassay or protein biomarker testing solutions from our Billerica, MA CLIA-certified laboratory (licensed in all 50 States). We serve hospital / medical centers, biotech / pharma and diagnostic testing businesses to meet advanced research and clinical testing needs.
We help develop, validate and implement immuno / protein assays to obtain high-quality protein biomarker data across therapeutic areas, technology platforms and sample types.Our services
Our highly experienced team serves customers straddling industry, research and clinical applications to deliver end-to-end immuno / protein assay solutions.Our solutions
ProterixBio has developed a novel combination of blood-based biomarkers for identifying COPD populations at higher risk for severe exacerbation, collaborating with leading academic medical centers and validating our assay in large, carefully curated cohorts.Our pipeline
As a CLIA laboratory, we perform the Critical Diagnostics Presage® ST2 Assay, which is indicated to be used in conjunction with clinical evaluation as an aid in assessing the prognosis of patients diagnosed with chronic heart failure.Our test menu
Billerica, MA, February 8, 2023: ProterixBio, Inc. today announced the offering of the Presage® ST2 Assay as a testing service through ProterixBio’s high-complexity CLIA laboratory. This Assay has been FDA…Read More
Billerica, MA, November 17, 2021: ProterixBio, Inc. (CLIA: 22D2189261) today announced it has received a Clinical Laboratory Permit from New York State Department of Health. This permit enables ProterixBio to…Read More